Cytokinetics reported $93.63M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 139.83M 65.09M
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Amgen AMGN:US $ 5203M 1325M
Arca Biopharma ABIO:US $ 53.36M 13.57M
Bayer BAYN:GR € 3412M 2373M
Biogen BIIB:US $ 2646.6M 897.3M
Brainstorm Cell Therapeutics BCLI:US $ 15.15M 3.7M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Capricor Therapeutics CAPR:US $ 51.42M 6.92M
Cytokinetics CYTK:US $ 93.63M 21.79M
Eisai 4523:JP Y 287815M 23426M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Exelixis EXEL:US $ 627M 96.27M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Geron GERN:US $ 76.06M 44.73M
Halozyme Therapeutics HALO:US $ 90.93M 26.9M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Novartis NOVN:VX SF 3625M 10227M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M